STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

NCT07631156 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction
Heart Failure
Ventricular Dysfunction, Left

Interventions

DRUG: Stepwise Withdrawal of ARNI and SGLT2i
DRUG: Continued Guideline-Directed Medical Therapy

Sponsor

Kyungsub Song

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]